These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 29576550

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Nuclear magnetic resonance-determined lipoprotein subclasses and carotid intima-media thickness in type 1 diabetes.
    Basu A, Jenkins AJ, Zhang Y, Stoner JA, Klein RL, Lopes-Virella MF, Garvey WT, Lyons TJ, DCCT/EDIC Research Group.
    Atherosclerosis; 2016 Jan; 244():93-100. PubMed ID: 26600440
    [Abstract] [Full Text] [Related]

  • 3. Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT/EDIC cohort: associations with carotid intima-media thickness.
    Lyons TJ, Jenkins AJ, Zheng D, Klein RL, Otvos JD, Yu Y, Lackland DT, McGee D, McHenry MB, Lopes-Virella M, Garvey WT, DCCT/EDIC Research Group.
    Diabet Med; 2006 Sep; 23(9):955-66. PubMed ID: 16922701
    [Abstract] [Full Text] [Related]

  • 4. Apolipoprotein-defined lipoproteins and apolipoproteins: associations with abnormal albuminuria in type 1 diabetes in the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort.
    Jenkins AJ, Yu J, Alaupovic P, Basu A, Klein RL, Lopes-Virella M, Baker NL, Hunt KJ, Lackland DT, Garvey WT, Lyons TJ, DCCT/EDIC Research Group.
    J Diabetes Complications; 2013 Sep; 27(5):447-53. PubMed ID: 23850262
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Data on carotid intima-media thickness and lipoprotein subclasses in type 1 diabetes from the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC).
    Basu A, Jenkins AJ, Zhang Y, Stoner JA, Klein RL, Lopes-Virella MF, Timothy Garvey W, Lyons TJ, DCCT/EDIC Research Group.
    Data Brief; 2016 Mar; 6():33-8. PubMed ID: 26759826
    [Abstract] [Full Text] [Related]

  • 10. Coronary Artery Disease Events and Carotid Intima-Media Thickness in Type 1 Diabetes in the DCCT/EDIC Cohort.
    Polak JF, Backlund JC, Budoff M, Raskin P, Bebu I, Lachin JM, DCCT/EDIC Research Group.
    J Am Heart Assoc; 2021 Dec 21; 10(24):e022922. PubMed ID: 34873921
    [Abstract] [Full Text] [Related]

  • 11. Serum apolipoproteins and apolipoprotein-defined lipoprotein subclasses: a hypothesis-generating prospective study of cardiovascular events in T1D.
    Basu A, Bebu I, Jenkins AJ, Stoner JA, Zhang Y, Klein RL, Lopes-Virella MF, Garvey WT, Budoff MJ, Alaupovic P, Lyons TJ, Diabetes Control Complications Trial/Epidemiology of Diabetes Interventions Complications Research Group.
    J Lipid Res; 2019 Aug 21; 60(8):1432-1439. PubMed ID: 31203233
    [Abstract] [Full Text] [Related]

  • 12. Effects of ursodeoxycholic acid therapy on carotid intima media thickness, apolipoprotein A1, apolipoprotein B, and apolipoprotein B/A1 ratio in nonalcoholic steatohepatitis.
    Ozel Coskun BD, Yucesoy M, Gursoy S, Baskol M, Yurci A, Yagbasan A, Doğan S, Baskol G.
    Eur J Gastroenterol Hepatol; 2015 Feb 21; 27(2):142-9. PubMed ID: 25533429
    [Abstract] [Full Text] [Related]

  • 13. Carotid intima media thickness is associated with plasma lipoprotein-associated phospholipase A2 mass in nondiabetic subjects but not in patients with type 2 diabetes.
    Constantinides A, van Pelt LJ, van Leeuwen JJ, de Vries R, Tio RA, van der Horst IC, Sluiter WJ, Dullaart RP.
    Eur J Clin Invest; 2011 Aug 21; 41(8):820-7. PubMed ID: 21281278
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Immune complexes containing modified lipoproteins are related to the progression of internal carotid intima-media thickness in patients with type 1 diabetes.
    Lopes-Virella MF, McHenry MB, Lipsitz S, Yim E, Wilson PF, Lackland DT, Lyons T, Jenkins AJ, Virella G, DCCT/EDIC Research Group.
    Atherosclerosis; 2007 Feb 21; 190(2):359-69. PubMed ID: 16530770
    [Abstract] [Full Text] [Related]

  • 19. Lipids and lipoprotein ratios: contribution to carotid intima media thickness in adolescents and young adults with type 2 diabetes mellitus.
    Shah AS, Urbina EM, Khoury PR, Kimball TR, Dolan LM.
    J Clin Lipidol; 2013 Feb 21; 7(5):441-5. PubMed ID: 24079285
    [Abstract] [Full Text] [Related]

  • 20. Indicators of the atherogenic lipoprotein phenotype measured with density gradient ultracentrifugation predict changes in carotid intima-media thickness in men and women.
    Maki KC, Dicklin MR, Davidson MH, Mize PD, Kulkarni KR.
    Vasc Health Risk Manag; 2012 Feb 21; 8():31-8. PubMed ID: 22272073
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.